Beijing Scitop Bio Tech Co Ltd (300858) — Capital Reinvestment Ratio
Beijing Scitop Bio Tech Co Ltd (300858) has a Capital Reinvestment Ratio of 1.59x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥44.72 Million) in capital expenditures (CN¥70.94 Million). Check 300858 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Beijing Scitop Bio Tech Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Beijing Scitop Bio Tech Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Beijing Scitop Bio Tech Co Ltd cash flow conversion.
Annual Capital Reinvestment Ratio for Beijing Scitop Bio Tech Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Beijing Scitop Bio Tech Co Ltd from 2015 to 2025. See Beijing Scitop Bio Tech Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.40x | CN¥123.44 Million | CN¥296.12 Million | ▲ +61.2% |
| 2024 | 1.49x | CN¥142.11 Million | CN¥211.50 Million | ▼ -10.6% |
| 2023 | 1.66x | CN¥107.27 Million | CN¥178.47 Million | ▲ +193.4% |
| 2022 | 0.57x | CN¥148.46 Million | CN¥84.18 Million | ▼ -7.5% |
| 2021 | 0.61x | CN¥110.27 Million | CN¥67.57 Million | ▲ +92.0% |
| 2020 | 0.32x | CN¥66.67 Million | CN¥21.28 Million | ▼ -32.2% |
| 2019 | 0.47x | CN¥98.27 Million | CN¥46.25 Million | ▼ -56.1% |
| 2018 | 1.07x | CN¥89.55 Million | CN¥95.99 Million | ▲ +90.6% |
| 2017 | 0.56x | CN¥84.00 Million | CN¥47.25 Million | ▼ -12.6% |
| 2016 | 0.64x | CN¥32.73 Million | CN¥21.06 Million | ▼ -69.5% |
| 2015 | 2.11x | CN¥2.69 Million | CN¥5.66 Million | — |